BiliaryTractCancer near Largo, FL

Care Philosophy: Dr Enas Abdallah is an Assistant Member in the Moffitt Cancer Center Department of Malignant Hematology. Dr Abdallah earned her MD from Ain Shams University in Cairo, Egypt. She completed an Internal Medicine Residency at Henry Ford Allegiance Health and a Geriatric Medicine Fellowship at Beaumont Health in Michigan. Dr Abdallah's clinical and scholarly interests are focused on inpatient management of malignant hematology patients. She will work closely with all members of the inpatient team to optimize care and outcomes.

Biography: Dr. Grogan received his PhD in Pharmacology and MD from the University of Kansas School of Medicine. He then completed an Internal Medicine Residency followed by a Physician-Scientist Training Program/Medical Oncology Fellowship (Neuro-Oncology Track) at the University of Wisconsin Hospitals and Clinics. Dr. Grogan joins Moffitt from the University of Wisconsin School of Medicine and Public Health, where he was a Faculty Clinical Instructor in Neuro-Oncology and Medical Oncology, Department of Medicine, and a Research Associate and Postdoctoral Research Fellow in the Department of Oncology, McArdle Laboratory for Cancer Research.Dr. Groganspecializes in the management of central nervous system malignancies, with a focus on treating patients with primary CNS cancers including both low- and high-grade gliomas. Hisclinical interests include precision and individualized treatment strategies for patientswith high-grade gliomaswhile also focusing heavily on quality-of-life considerations.

Care Philosophy: Dr Xie is a hematologist and assistant member in the Moffitt Cancer Center Malignant Hematology Department. Dr Xie completed her hematology/oncology fellowship training at the Mayo Clinic, Rochester, MN, Master of Science in Clinical Research and Geriatric fellowship training at the UCLA, Ronald Reagan Medical Center. She focuses on treating myeloid malignancies and precursor stages, including clonal hematopoiesis of indeterminate potential (CHIP), clonal cytopenia (CCUS), MDS, MPN, CMML, and Acute Leukemia. Her research focuses on clinical and translational science, including identifying and preventing cancer at early stage, bridging bench-to-bedside research with designing novel therapeutics and clinical trials.

Care Philosophy: Dr John Mullinax is an Associate Member in the Sarcoma Department and Immunology Department of Moffitt Cancer Center and Associate Professor in the Department of Surgery at the University of South Florida Morsani College of Medicine. He is the Surgical Director of the Cellular Immunotherapy Program and the Associate Program Director for the Complex General Surgical Oncology fellowship at Moffitt. Dr Mullinax is board-certified in both Surgery and Complex General Surgical Oncology by the American Board of Surgery. Dr Mullinax's primary clinical focus is the surgical management of patients with soft tissue sarcoma throughout the body, to include retroperitoneal sarcoma and gastrointestinal stromal tumors.

Care Philosophy: Dr Bejanyan is an Associate Member, Program Leader of Blood and Marrow Transplant (BMT) and Head of the Leukemia/Myeloid Section of the BMT and Cellular Immunotherapy Department at Moffitt Cancer Center. She is an Associate Professor in Oncologic Sciences at the University of South Florida.Dr Bejanyan also served as the Clinical Scientific Co-Director of Moffitt Pharmacokinetics and Pharmacodynamics Core. As a physician investigator with clinical and research expertise in BMT and cellular immunotherapies for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), Dr Bejanyan focuses in advancing clinical and translational research by fostering innovative immune cell therapy strategies to treat leukemia.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Locke is a medical oncologist and translational researcher in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. He leads the Immune Cell Therapy (ICE-T) initiative at Moffitt, an integrated cross-departmental translational team. Dr Locke is a clinical research leader in the field of Chimeric Antigen Receptor (CAR) T cell therapy, acting as a national P.I. for several pivotal trials of anti-CD19 CARs for lymphoma. In addition, Dr Locke is translating findings from his laboratory into new cellular immunotherapies such as the Moffitt created whole protein survivin tumor vaccine for multiple myeloma. Dr Locke graduated with a B.S.

Care Philosophy: Dr David Sallman is an Assistant Member in the Department of Malignant Hematology at Moffitt Cancer Center. Dr Sallman's clinical interests are myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). Dr Sallman earned his MD degree from the University of South Florida College of Medicine. He completed an Internal Medicine Residency at Massachusetts General Hospital and, most recently, a Hematology/Oncology Fellowship at Moffitt Cancer Center.

Care Philosophy: Dr Isenalumehe earned her MD from Sophie Davis School of Biomedical Education, CUNY Medical College, City College of New York (BA/MD Program) / Albany Medical College, New York and her MS degree in Clinical and Biomedical Investigation from the University of Southern California, Los Angeles. She completed a combined Internal Medicine and Pediatric Residency at NJMS-Rutgers (former: University of Medicine and Dentistry of New Jersey, Newark, where she also served as Internal Medicine-Pediatrics Chief Resident. She completed a Pediatric Hematology-Oncology Fellowship at Children's Hospital of Los Angeles, University of Southern California, where she also served as Chief Fellow.

Care Philosophy: At Moffitt Cancer Center we are working tirelessly in the areas of patient care research and education to advance one step further in fighting cancer As a National Cancer Institute designated Comprehensive Cancer Center we are committed to the health and safety of our patients and dedicated to providing expert cancer care From enhanced quality of life to complete remission Moffitt is Florida s top choice aiming to achieve the best outcome for each patient

Care Philosophy: Dr Voss received an MD from the Ohio State University College of Medicine and an MPH in Epidemiology from the University of Texas Health Sciences Center at Houston. She completed a General Surgery Residency at the University of California San Diego Medical Center, and most recently completed a Complex General Surgical Oncology Fellowship at the University of Texas MD Anderson Cancer Center. Dr Voss's clinical interests include extremity sarcomas, complex retroperitoneal and abdominal sarcomas, GISTs, and adrenal tumors (both benign and malignant).

Care Philosophy: At Tampa General Medical Group, we are committed to partnering with our patients to help them achieve their best health possible. We strive to provide high-quality, personalized, cost-effective care to our patients by listening to their medical concerns and encouraging their involvement in important decisions. Our board-certified internal medicine and family medicine physicians and pediatricians take pride in focusing on improved health through prevention and evidence-based care. Our goal is to empower our patients to advocate for their health.

Biography: Dr. Suzanne Gozdanovic, MD is a General Surgery Specialist who practices in St Petersburg, FL. She is 44 years old. Dr. Suzanne Gozdanovic, MD is affiliated with HCA Florida Northside Hospital and HCA Florida Saint Petersburg Hospital.

Care Philosophy: Dr Dam received his MD degree from Boston University School of Medicine and completed an Internal Medicine Residency at Boston University Medical Center. Following his residency he completed a Gastroenterology Fellowship at Albany Medical Center, New York, and an Advanced Endoscopy Fellowship at Carolinas Medical Center, Division of Gastroenterology and Hepatology, Charlotte, North Carolina. Dr Dam's clinical interests include endoscopic therapy for Barrett's esophagus, endoscopic mucosal resection (EMR), luminal stenting, management of pancreatic-biliary disorders and screening for colorectal cancer.

Care Philosophy: Dr Mok received his MD from Ross University School of Medicine. He completed an Internal Medicine Residency at Cooper Medical School of Rowan University, where he also served as Chief Resident, followed by a Gastroenterology Fellowship at the same institution, where he also served as Chief Fellow. He completed additional fellowship training in Advanced Endoscopy at Geisinger Medical Center in Danville, Pennsylvania and served as an Assistant Professor at the Case Western Reserve University School of Medicine. Dr Mok is currently the Program Director for Moffitt's Advanced Endoscopy Fellowship. Dr Mok's clinical interests include therapeutic endoscopic ultrasound/ERCP and adjunct/alternative therapy for cancer.

Care Philosophy: Dr Peva's clinical and research interests' include the treatment for Barrett's esophagus and early esophageal cancer using endoscopic mucosal resection (EMR) and mucosal ablation including radiofrequency ablation and cryoablation endoscopic retrograde cholangiopancreatography (ERCP) for biliary and pancreatic disorders including cancer, esophageal stenting and wireless capsule endoscopy for small bowel evaluation. Additional research interests include endoscopic outcomes and capsule endoscopy.

Care Philosophy: Dr Friedman earned his MD degree at the SUNY Downstate Medical Center. He completed an Internal Medicine Residency at George Washington University Medical Center and a Gastroenterology Fellowship at Albany Medical Center. After completing training, Dr Friedman worked with Gastrohealth in Miami, Florida for 3 years. He currently is an Associate Member in the department of GI Oncology at Moffitt Cancer Center. He also holds an academic appointment as an Assistant Professor in the department of Oncological Sciences at the University of South Florida. Dr Friedman's clinical interests are in 1) Colorectal cancer screening 2) Genetic Colorectal Cancer Syndromes 3) Surveillance of pre-malignant Intestinal Conditions.